AQR Capital Management LLC Sells 1,495 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

AQR Capital Management LLC trimmed its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 7.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 17,409 shares of the medical instruments supplier’s stock after selling 1,495 shares during the period. AQR Capital Management LLC’s holdings in Mettler-Toledo International were worth $24,331,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in MTD. Eisler Capital UK Ltd. purchased a new stake in Mettler-Toledo International in the 4th quarter valued at $770,000. Daiwa Securities Group Inc. raised its holdings in shares of Mettler-Toledo International by 36.6% in the first quarter. Daiwa Securities Group Inc. now owns 2,682 shares of the medical instruments supplier’s stock valued at $3,570,000 after purchasing an additional 719 shares during the last quarter. Capital International Investors raised its holdings in shares of Mettler-Toledo International by 3.0% in the fourth quarter. Capital International Investors now owns 933,989 shares of the medical instruments supplier’s stock valued at $1,132,891,000 after purchasing an additional 27,386 shares during the last quarter. Norden Group LLC lifted its position in shares of Mettler-Toledo International by 2,701.7% during the first quarter. Norden Group LLC now owns 6,640 shares of the medical instruments supplier’s stock valued at $8,840,000 after purchasing an additional 6,403 shares in the last quarter. Finally, Parkman Healthcare Partners LLC purchased a new position in Mettler-Toledo International during the fourth quarter worth about $9,097,000. 95.07% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, insider Christian Magloth sold 1,000 shares of the business’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the completion of the transaction, the insider now directly owns 734 shares in the company, valued at approximately $1,044,459.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the completion of the sale, the insider now owns 734 shares of the company’s stock, valued at $1,044,459.98. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Shawn Vadala sold 250 shares of the company’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total value of $350,250.00. Following the completion of the transaction, the chief financial officer now owns 4,914 shares in the company, valued at $6,884,514. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on MTD. Evercore ISI lifted their target price on shares of Mettler-Toledo International from $1,375.00 to $1,390.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 2nd. Wells Fargo & Company began coverage on Mettler-Toledo International in a report on Tuesday, August 27th. They set an “equal weight” rating and a $1,400.00 price target on the stock. JPMorgan Chase & Co. upped their price objective on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Stifel Nicolaus lifted their target price on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the stock a “buy” rating in a research note on Monday, August 5th. Finally, Jefferies Financial Group restated an “underperform” rating and set a $1,250.00 price target (up previously from $1,230.00) on shares of Mettler-Toledo International in a research report on Monday, June 3rd. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Mettler-Toledo International presently has an average rating of “Hold” and an average target price of $1,356.25.

Mettler-Toledo International Price Performance

NYSE:MTD opened at $1,499.70 on Tuesday. Mettler-Toledo International Inc. has a 1 year low of $928.49 and a 1 year high of $1,546.93. The stock’s fifty day moving average price is $1,419.52 and its two-hundred day moving average price is $1,382.39. The company has a market cap of $32.03 billion, a P/E ratio of 42.06, a P/E/G ratio of 3.75 and a beta of 1.14.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, topping the consensus estimate of $9.00 by $0.65. Mettler-Toledo International had a negative return on equity of 575.61% and a net margin of 20.95%. The business had revenue of $946.75 million during the quarter, compared to the consensus estimate of $929.13 million. During the same quarter last year, the company earned $10.19 EPS. The firm’s revenue was down 3.6% compared to the same quarter last year. On average, analysts expect that Mettler-Toledo International Inc. will post 40.35 earnings per share for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.